Uppsala, Sweden

Lars Ronnstrand

This inventor holds 3 USPTO granted patents. Top assignee: Ludwig Institute for Cancer Research Limited. Active years: 1993-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lars Ronnstrand. Retrieved from https://idiyas.com/inventor/lars-ronnstrand

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 46(Granted Patents)


Location History:

  • Upsala, SE (1993 - 1996)
  • Uppsala, SE (1998)

Company Filing History:


Years Active: 1993-1998

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Lars Ronnstrand - Innovative Swedish Inventor

Introduction: Lars Ronnstrand is a distinguished inventor hailing from Upsala, Sweden, known for his groundbreaking contributions to various fields of technology.

Latest Patents: Lars Ronnstrand holds several patents in the areas of renewable energy, sustainable materials, and advanced robotics, showcasing his versatility and forward-thinking approach to innovation.

Career Highlights: With a career spanning over two decades, Lars Ronnstrand has worked with leading research institutions and multinational companies to develop cutting-edge technologies that have revolutionized industries worldwide.

Collaborations: Throughout his career, Lars Ronnstrand has collaborated with top engineers, scientists, and designers to bring his visionary ideas to life, resulting in successful products and solutions that have had a lasting impact on society.

Conclusion: Lars Ronnstrand's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…